Dermapharm Holding SE, DE000A2GS5D8

Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Published on 08/11/2026 at 08:00 | dgap.de

Dermapharm Holding SE / DE000A2GS5D8

EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements


11.08.2026 / 08:00 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Financial report of the group (half-year/Q2)

Language: German
Date of disclosure: August 25, 2026
Address: https://ir.dermapharm.de/de/investor-relations/finanzberichte-praesentationen/

Language: English
Date of disclosure: August 25, 2026
Address: https://ir.dermapharm.de/en/investor-relations/financial-reports-presentations/


11.08.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News
Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de
LEI Code: 5299009F0KNZINQQQK37

 
End of News EQS News Service

2376924  11.08.2026 CET/CEST
en | DE000A2GS5D8 | DERMAPHARM HOLDING SE | boerse | 69935918 |